You just read:

The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

News provided by

Regeneron Pharmaceuticals, Inc.

Sep 20, 2019, 06:59 ET